| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kaytlyn A. Gerbin | |
| Charles E. Murry | |||
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 | ||
| Stem cell treatment for acute myocardial infarction | Q24203736 | ||
| Heart regeneration | Q24562846 | ||
| Mammalian heart renewal by pre-existing cardiomyocytes | Q24632538 | ||
| FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction | Q24679353 | ||
| Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network | Q26821783 | ||
| Coordinating tissue interactions: Notch signaling in cardiac development and disease | Q26822995 | ||
| A neonatal blueprint for cardiac regeneration | Q26827943 | ||
| Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy | Q27322954 | ||
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury | Q28252995 | ||
| Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium | Q28586848 | ||
| The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium | Q29614435 | ||
| Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators | Q29619969 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Cell therapy for cardiac repair--lessons from clinical trials. | Q30359782 | ||
| c-kit expression identifies cardiovascular precursors in the neonatal heart | Q30486058 | ||
| HLA engineering of human pluripotent stem cells | Q30540471 | ||
| Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes | Q30574106 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 | ||
| Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN). | Q33824505 | ||
| Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts | Q33887672 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy | Q33919886 | ||
| Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial | Q33950809 | ||
| c-kit+ cells minimally contribute cardiomyocytes to the heart | Q34021586 | ||
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial | Q34074673 | ||
| Marching towards regenerative cardiac therapy with human pluripotent stem cells | Q34087548 | ||
| LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction | Q34090699 | ||
| Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. | Q34133412 | ||
| Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming | Q34245487 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats | Q34355730 | ||
| p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes | Q34415888 | ||
| Cell-based cardiac repair: reflections at the 10-year point | Q34467391 | ||
| Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial | Q34467911 | ||
| Activation of Notch signaling pathway precedes heart regeneration in zebrafish | Q34582440 | ||
| Cardiac cell therapy: where we've been, where we are, and where we should be headed | Q35144550 | ||
| Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
| Bioengineering heart muscle: a paradigm for regenerative medicine | Q36117532 | ||
| Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. | Q36512389 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial | Q36694346 | ||
| Cell-based therapy of myocardial infarction | Q36977051 | ||
| Cardiomyocyte death and renewal in the normal and diseased heart. | Q37134621 | ||
| Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) | Q37625636 | ||
| The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine | Q37720654 | ||
| Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair. | Q37808802 | ||
| Regenerative medicine for the treatment of heart disease | Q38075104 | ||
| Key developments in stem cell therapy in cardiology | Q38076435 | ||
| Patching the heart: cardiac repair from within and outside | Q38136924 | ||
| Heart regeneration with engineered myocardial tissue | Q38211168 | ||
| Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function | Q38452784 | ||
| Human myocardial grafts: do they meet all the criteria for true heart regeneration? | Q39456758 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts | Q41980314 | ||
| Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model | Q41989199 | ||
| Expression of concern: the SCIPIO trial | Q42354504 | ||
| Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice | Q45171605 | ||
| Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy. | Q46976235 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. | Q52175867 | ||
| Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. | Q53518426 | ||
| Cardiopoietic Stem Cell Therapy in Heart Failure | Q57779306 | ||
| Comparison of human skeletal myoblasts and bone marrow-derived CD133+progenitors for the repair of infarcted myocardium | Q58108846 | ||
| Myoblast transplantation for heart failure | Q58109127 | ||
| Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 | ||
| Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction | Q82750318 | ||
| Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction | Q83697673 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 133-40 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Cardiovascular Pathology | Q1992658 |
| P1476 | title | The winding road to regenerating the human heart | |
| P478 | volume | 24 |
| Q92826247 | Advances in stem cell research and therapeutic development |
| Q47137765 | Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. |
| Q26799939 | Bridging Basic Science with Cardiac Surgery: The Bristol Heart Institute Experience |
| Q58565104 | Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q91291231 | Cardiac repair and the putative role of stem cells |
| Q89519147 | Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine |
| Q64996551 | Cardiovascular progenitor cells cultured aboard the International Space Station exhibit altered developmental and functional properties. |
| Q26765916 | Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration |
| Q37713328 | Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration |
| Q39149000 | Concise Review: Mending a Broken Heart: The Evolution of Biological Therapeutics. |
| Q88585933 | Concise Review: The Regenerative Journey of Pericytes Toward Clinical Translation |
| Q44872219 | Contributions of bone morphogenetic proteins in cardiac repair cells in three-dimensional in vitro models and angiogenesis |
| Q41615246 | Direct Cardiac Reprogramming: Advances in Cardiac Regeneration |
| Q33657616 | Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology |
| Q59800422 | Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction |
| Q59791034 | Heart Regeneration in the Mexican Cavefish |
| Q64093603 | Human Heart Explant-Derived Extracellular Vesicles: Characterization and Effects on the In Vitro Recellularization of Decellularized Heart Valves |
| Q64975937 | Human Pluripotent Stem Cell-Derived Engineered Tissues: Clinical Considerations. |
| Q89403753 | Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates |
| Q36757779 | Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist fo |
| Q40986431 | Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction |
| Q39663325 | Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging |
| Q47871478 | Myocardial Tissue Engineering for Regenerative Applications |
| Q28078093 | New Treatment Strategies for Alcohol-Induced Heart Damage |
| Q34531894 | Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease |
| Q48028186 | Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium |
| Q38989011 | Proceedings: Moving Toward Cell-Based Therapies for Heart Disease |
| Q36504298 | Reaching out: junctions between cardiac telocytes and cardiac stem cells in culture |
| Q45290478 | Rebuilding the infarcted heart with noncellular material |
| Q41494185 | Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy |
| Q50903563 | Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come. |
| Q38904719 | Roles of exosomes in cardioprotection |
| Q52726988 | Short-term hypoxia improves early cardiac progenitor cell function in vitro. |
| Q90254627 | Sustained miRNA release regenerates the heart |
| Q89459395 | Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model |
| Q50434150 | Synchronization of excitable cardiac cultures of different origin |
| Q38850633 | The Future of Cardiovascular Regenerative Medicine |
| Q50081195 | The Secret Life of Exosomes: What Bees Can Teach Us About Next-Generation Therapeutics |
Search more.